Acne Procedural denied as duplicate or overlapping therapy by Humana?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for acne procedural are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Acne Procedural
## Why Humana Denied Acne Procedural Treatment: Duplicate Therapy
A duplicate-therapy denial means Humana has identified that your plan already covers — or has recently paid for — a treatment it considers therapeutically equivalent to the procedure being requested. For acne procedural treatments (such as chemical peels, light or laser therapy, intralesional injections, or comedone extraction), this typically means an active prescription therapy or a recently paid procedural claim is considered to overlap with the new request.
## Why This Denial Is Appealable
Different acne procedural modalities are not clinically interchangeable. A light-based therapy addresses a different mechanism than an intralesional injection; a chemical peel is not equivalent to a laser resurfacing session. Your appeal should establish the distinct clinical purpose, mechanism, and patient population for the specific procedure requested — and document why the existing treatment does not address the same therapeutic need. Your dermatologist's documentation is essential here.
## Federal Appeal Framework
- Internal appeal: Under ERISA §503 and ACA §2719, you have the right to a full internal appeal. File within the deadline on your denial letter.
- External review: If Humana upholds the denial internally, an accredited IRO can conduct an independent review. The standard window is up to four months from final internal denial. Expedited review is available when delay would seriously jeopardize your health.
## Documentation to Gather
1. Dermatologist's clinical letter — A letter from your treating dermatologist explaining the specific indication, mechanism, and goal of the requested procedure and why the currently covered treatment does not address it. 2. Treatment history — Records showing the timeline, dosage, and response (or lack of response) to the existing treatment Humana considers duplicative. 3. Diagnosis specificity — Chart documentation distinguishing the clinical subtype, anatomic location, or severity pattern that requires the additional procedure. 4. Humana's clinical policy — Request Humana's current coverage policy for acne procedural treatments. Identify the exact duplicate-therapy rule invoked and any exception pathway. 5. Applicable specialty-society guidance — Ask your dermatologist to reference the American Academy of Dermatology (AAD) guideline on acne management that supports using the requested procedure alongside or instead of the existing therapy.
## Criteria-Mapping Structure
In your appeal letter, address each element of Humana's duplicate-therapy finding directly: identify what treatment is considered duplicative, explain the clinical distinction between that treatment and the one requested, and cite the specific chart note or guideline that supports the distinction. A side-by-side comparison table (existing treatment vs. requested procedure: mechanism, indication, expected outcome) is a clear and persuasive format.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →